Skip to main content

Table 2 Complications of dual PDE5i therapy

From: Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study

 

n

Headache

3

Diarrhea

2

Hot Flash

4

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us